Rivaroxaban reduced stroke and systemic embolism compared with warfarin in nonvalvular AF.
Publication
, Journal Article
Klein, L
Published in: Ann Intern Med
January 17, 2012
Duke Scholars
Published In
Ann Intern Med
DOI
EISSN
1539-3704
Publication Date
January 17, 2012
Volume
156
Issue
2
Start / End Page
JC1 / JC3
Location
United States
Related Subject Headings
- General & Internal Medicine
- 3202 Clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Klein, L. (2012). Rivaroxaban reduced stroke and systemic embolism compared with warfarin in nonvalvular AF. Ann Intern Med, 156(2), JC1–JC3. https://doi.org/10.7326/0003-4819-156-2-201201170-02003
Klein, Liviu. “Rivaroxaban reduced stroke and systemic embolism compared with warfarin in nonvalvular AF.” Ann Intern Med 156, no. 2 (January 17, 2012): JC1–3. https://doi.org/10.7326/0003-4819-156-2-201201170-02003.
Klein L. Rivaroxaban reduced stroke and systemic embolism compared with warfarin in nonvalvular AF. Ann Intern Med. 2012 Jan 17;156(2):JC1–3.
Klein, Liviu. “Rivaroxaban reduced stroke and systemic embolism compared with warfarin in nonvalvular AF.” Ann Intern Med, vol. 156, no. 2, Jan. 2012, pp. JC1–3. Pubmed, doi:10.7326/0003-4819-156-2-201201170-02003.
Klein L. Rivaroxaban reduced stroke and systemic embolism compared with warfarin in nonvalvular AF. Ann Intern Med. 2012 Jan 17;156(2):JC1–JC3.
Published In
Ann Intern Med
DOI
EISSN
1539-3704
Publication Date
January 17, 2012
Volume
156
Issue
2
Start / End Page
JC1 / JC3
Location
United States
Related Subject Headings
- General & Internal Medicine
- 3202 Clinical sciences
- 11 Medical and Health Sciences